Form 4: Protara CFO Sells Shares for Tax Obligations

Protara Therapeutics' Chief Financial Officer, Patrick Fabbio, disposed of 3,261 common shares to cover tax liabilities from a Restricted Stock Unit award vesting.

Summary

• Patrick Fabbio, Chief Financial Officer of Protara Therapeutics, Inc., disposed of 3,261 shares of common stock.
• The transaction occurred on January 26, 2026, at a price of $6.67 per share.
• These shares were withheld by Protara Therapeutics to satisfy income tax obligations related to the vesting of a Restricted Stock Unit (RSU) award.
• The RSU award was originally granted to Mr. Fabbio on January 24, 2025.
• Following this transaction, Mr. Fabbio directly beneficially owns 64,115 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding related to RSU vesting, which is a neutral event. It reflects the executive receiving compensation but does not indicate a discretionary sale or purchase.

Positives

• The transaction indicates the vesting of a Restricted Stock Unit (RSU) award, suggesting the executive met performance or tenure requirements.

Negatives

• The disposition of shares, even for tax purposes, reduces the executive's direct ownership in the company.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to executive compensation and tax obligations, common across all industries for publicly traded companies with equity compensation plans. It does not reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact, as it's a routine tax-related disposition of a small number of shares by an executive. It slightly reduces the executive's direct ownership.
• Employees: No direct impact on general employees.

Key Dates

Keywords

Protara Therapeutics, TARA, Patrick Fabbio, CFO, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Unit, RSU Vesting